Professor OF SURGERY
Resume:
BIOGRAPHICAL
Giovanni Ambrosino
Pietradefusi (AV) Italy
Dept. of General – Oncology and
Laparoscopic Surgery
High Specialty in Hepatic - Biliary
Pancreatic Surgery.
******************@*****.***
Giovanni Ambrosino, M.D.
Name:
Birth date:
Birth place:
Office address:
Telephone #:
Cell:
Personal e-mail:
Home address:
South Italian address
California Resident Address
Citizenship:
USA VISA
Via Francesco Bocchi 49 Adria
45011 (RO) ITALY
Via Roma 137- Pietradefusi(AV)
83030
12012 Mitchell ave #7
Los Angeles 90066
Italian
Eb1 /E11- Permanent Resident -
Green Card Visa -
for extraordinary ability
SSN ***-**-****
Prof Ambrosino is considered (Eb1 Visa for Extraordinary ability) one of the leading expert in the world for:
- Liver Transplant
- Bioartificial Liver Support System
- Liver cell Transplantation
- Stereotactic Radiosurgery for Unresecable Tumor
- Complementary Therapy in oncology patients (phyto-therapy) Giovanni Ambrosino, M.D.
2
PROFESSIONAL EDUCATION – TRAINING AND EXPERIENCE
Dates Institution and location Degree and year
Graduate
1978-1984 State University M.D. 1984
Padova, Italy
Post Graduate
Dates Name and Location of Institution Position-Program Head 1985 General Surgical Service First Year Resident
Harvard Medical School in General Surgery
Mass. General Hospital Prof. G. Nardi
Boston – MASS Prof. F.Del Monico
Mayo Clinic Dr. R. Beart
Rochester Minnesota Abdominal Surgery
New York University Prof. B. Cohen
New York Physiology of GI Tract
According with the
University of Padova
And Italian Minister of Health
DPR. 20.12.1979, n.761art.24
D.M.301. 1982.
1986 Thomas Starzl Transplantation Service Second Year Resident University of Pittsburgh
Clinical Transplant Fellow STAFF
Pittsburgh, Pennsylvania Prof. Thomas E Starzl
According with the
University of Padova
And Italian Minister of Health
DPR. 20.12.1979, n.761art.24
D.M.301. 1982.
1987 Thomas Starzl Transplantation Service Third Year Resident Giovanni Ambrosino, M.D.
3
University of Pittsburgh
Pittsburgh, Pennsylvania Clinical Transplant Fellow STAFF 1989
Prof. Thomas E Starzl
According with the University of
Padova
And Italian Minister of Health
DPR. 20.12.1979,
n.761art.24 D.M.301. 1982.
Postgraduate in General and Emergency Surgery with 50/50 and first-class honours degree University of Padova School. of Medicine.
1990 - 1992. Postgraduate in Microsurgery and Experimental Surgery with 70/70 and first-class honours degree. University of Milan - School of Medicine. 1993 - 1994
1999
ATLS
American College of Surgeon
Bologna - Italy
Interventional Angiology - First Class Honours - University of Padova - School of Medicine
1887
Giovanni Ambrosino, M.D.
4
FOREIGN SURGICAL AND RESEARCH EXPERIENCES
The following experiences were economically supported by the Padova University Hospital For the specific activities see the certificates attached at the end of the CV Dates Institution Acivities
October 1989 T. Starzl Transplantation Institute Liver Transplant UPMC Pittsburgh PA
September1990 T. Starzl Transplantation Institute Liver Transplant UPMC Pittsburgh PA
November-December California Pacific Medical Center Pediatric Liver Transplant 1991 Los Angeles CA Prof. C.O.Esquivel
January and February California Pacific Medical Center Pediatric Liver Transplant 1992 Los Angeles CA Prof. C.O.Esquivel
October1993. California Pacific Medical Center Pediatric Liver Transplant Los Angeles CA Prof. C.O.Esquivel
February 1995, T. Starzl Transplantation Institute Cell Transplantation UPMC Pittsburgh PA
December 1996 University Of Lebanon Bioartificial Liver Program Beirut Arab University Prof. A. Risck
November – December Mount Sinai Hospital Major Liver Resection 1996 New York Prof. C. Miller
October-November Massachussets General Hospital General and Thoracic Surgery 1997 Boston - MASS Prof. Virchow
April –June Liver GI Transplantation Service Intestinal and Multivisceral 1997 Jackson Memorial Hospital Miami Transplantation Prof. A. Tzakis
Giovanni Ambrosino, M.D.
5
May - June – July Diabetics Research Institute Cell Transplantation 1998 Miami Prof. Camillo Ricordi
October 1998 GI Transplantation Service Bioartificial Liver Loyola University Chicago Prof. D. Van Thiel and Dr. Brems March 1999 Cedar Sinai Medical Center Bioartificial Liver Los Angeles Prof. Demetriou
March – April Dept. of Surgery And Organ Transplant Xenotranplantation program 2000 University of Cape-Town South Africa Prof. D. Khan June Dept of thoracic Surgery
2001 Mass. General Hospital Boston
New York University
New York
February 2002 T. Starzl Transplantation Institute
UPMC Pittsburgh PA
October – November Dept of Laparoscopic Surgery
2003 Cedar Sinai Medical Center
Dept of robotic and minimally Invasive Surgery
Hackensack University Medical Center
Giovanni Ambrosino, M.D.
6
ACCADEMIC APPONTMENTS
Years Institution and Location Title
1989– 2001 Dept of Surgery Instructor of:
Post Graduate School Microsurgery
In Emergency Surgery Experimental Surgery
University of Padova Emergency Surgery
Assistant Professor of Surgery
1987 – 1988 Staff Training School Instructor of:
CC.EE.OO.DD. Health Administration
Noale – Italy
1988 – 2002 Dept of Orthopedics Instructor of:
Post Graduate School General Surgery
Orthopedics Microsurgery
1997 Transplantation Organ Service Instructor of:
International Course Liver Transplantation
University of Padova
1999 RUI Foundation Instructor of:
. Ethical issue in Organ Transplantation
2001 – 2004 Dept of Surgery Instructor of:
Post Graduate School General Surgery
General Surgery
University of Padova
2005 Dept of Surgery Professor of Surgery
Post Graduate School
General Surgery
University of Padova
Giovanni Ambrosino, M.D.
7
HOSPITAL APPONTMENTS
Years Institution and location Title
1985 – 1987 - Thomas Starzl Transplantation Service Staff In liver Transplant Presbyterian University Hospital
1988-1992 Dept. of Emergency Surgery Staff
Hospital of Noale (VE)
1992 - 2003 Dept of General, Vascular and Staff
Liver Transplant Surgery
I Dept. Of Surgery
University of Padova
2004- 2007 Department of General and
Hepatic- Pancreatic Surgery Chief Of Surgery. Chairman DPT Radiosurgery Center
San Bortolo Hospital Vicenza Italy
2012 - 2015 Department of General, Oncology
and Laparoscopic Surgery Chief Of Surgery. Chairman DPT High Specialty in
Hepatic-Biliary – Pancreatic Surgery
Neuromed IRCCS Avellino
2015 October Department of General, Oncology
and Laparoscopic Surgery Chief Of Surgery. Chairman DPT High Specialty in
Hepatic-Biliary – Pancreatic Surgery
Santa Rita Clinics Atripalda (AV) Italy
LICENSURE
- ITALIAN MEDICAL LICENCE
- ITALIAN MEDICAL LICENCE FOR ORGAN TRANSPLANTATION (since 1990)
- AMERICAN LIVER TRANSPLANT BOARD
Giovanni Ambrosino, M.D.
8
HOSPITAL COMMITEES
Padova University Hospital Artificial and bioartificial liver support PATENTS
Patent: PCT # US97/22727 – WO 98/25637
Dr. Ambrosino is inventor of a new bioartificial liver, named ALEX, containing a NEW AUTOLOGOUS BIOMATRIX for hepatocyte support.
Clinical Phase I-II
NATIONAL AND INTERNATIONAL RESEARCH PROGRAM
HEAD OF:
- BIOARTIFICIAL LIVER PROGRAM between:
University of Padova
Loyola University, GI Liver Transplantation Service Lebanon University, General Surgery Service Beiruth University of Moscow – Space Center - Moscow
University of Trieste
University of Roma “La Sapienza”
University of Roma “Campus Bio-Medico”
University of Calabria
- CELL TRANSPLANTATION AND GENE THERAPY between:
University of Padova
Diabetics Research Institute, Miami
University of Cape Town – South Africa
Coll: Cell Transplantation Program – University of Pittsburgh - Prof. S. Strom
- STEREOTACTIC ROBOTIC SURGERY
Stanford University
Giovanni Ambrosino, M.D.
9
NATIONAL AND INTERNATIONAL REMARKABLE ACTIVITIES
- First in EUROPE to treat a patient affected of an acute liver failure with a BIOARTIFICIAL LIVER. The patient is alive.
- First in Italy to perform a DOMINO LIVER TRANSPLANT Both patients are alive
- First in Italy to perform a Liver donor in a child 20 days old. The liver was sent to Geneva and transplanted successfully 2001 First IN THE WORLD - treatment anesthetic free with an HEPATOCYTES TRANSPLANTATION, to treat a CRIGLER NAJJAR SYNDROME 2004 First IN THE WORLD - treatment of patient with LIVER CANCER using ROBOTIC STEREOTACTIC SURGERY.
1. Special Award HARVARD MEDICAL SCHOOL (Islet Pancreatic Research) - 1985 2. AWARDS FOR 2 RESEARCHES PROGRAM FROM THE VENETO REGION
“RICERCA FINALIZZATA” 1999
a. “A new program for detecting Quality Of Life In Patient Waiting And Liver Transplanted. PEQUOL – Personal Quality Of Life
b. Biotechnology – A New Bioartificial liver - ALEX 3. AWARD FOR HEPATOCYTES TRANSPLANTATION RESEARCH – Orlando (FL)
-2002
4. AWARD FOR DONOR LIVER PROGRAM IN SOUTH ITALY - 2001 5. WHO’S WHO IN MEDICINE AND HEALTHCARE 2004 – 2005 6. AWARD – ITALIAN EXCELLENCE IN THE WORLD - 2011
7. AWARD – ITALIAN EXCELLENCE IN THE WORLD - 2012
8. INTERNATIONAL AWARD IN MEDICAL SCIENCE – XV EDITION – PADRE PIO- 2015 9. FIRST WINNER PRIZE – Hollywood International Moving Picture Film Festival – Screenplay section (2016)
Giovanni Ambrosino, M.D.
10
MEMBERSHIP PROFESSIONAL AND SCIENTIFIC SOCIETIES
- Academy of Surgical Research
- ASAIO – American Society of Artificial Internal Organ
- American Association for the Advancement of Science
- Italian Alumni Association Mass General Hospital – Harvard Medical School Boston MA
- Italian Surgical Society
- Società Italiana Polispecialistica Giovani Chirurghi NATIONAL RESPONSIBLE (1995) for General and Emergency Surgery
- International Microsurgery Society
- Società di Fisiopatologia Chirurgica
- International Federation of Human Right – ITALIAN VICE PRESIDENT (2000)
- EDITORIAL BOARD – OBM Transplantation
- EDITORIAL BOARD – JOURNAL OF TRANSPLANTATION RESEARCH AND TECHNOLOGY
SCIENTIFIC PUBLICATIONS
200 Scientific Papers
1775 citations Google Scholar
4 Books
Giovanni Ambrosino, M.D.
11
GRANTS
1. Principal Investigator: Bioartificial Liver Support, sponsored by Padova University Hospital, Veneto Region, Private Company, Banks.
2. Principal Investor: Hepatocyte Transplantation, sponsored by University of Padova, Veneto Region, Private Company.
3. Principal Investigator: Quality of life in pre and post transplant patients, sponsored by Padova University Hospital, Veneto Region.
4. Principal Investigator (1985) Randomised study on new antibiotics therapy in acute cholangitis Sponsored by Caro-Erba
5. Investigator: New antibiotic BMS-284756, to treat postoperative infection: randomized study;
(FDA) sponsored by Bristol-Myers-Squibb.
Giovanni Ambrosino, M.D.
12
INTEREST
- Student and Resident Surgery teaching
- Liver Transplant - Hepatobiliary and pancreatic surgery
- Complementary Therapy (phyto)
- Laparoscopic surgery - Oncology
- Development of new liver support – artificial and bioartificial liver
- Gene therapy
- Critical care in liver transplantation
- New technique for procurement of grafts from living donors
- Development of living-related donor liver transplant in countries without a brain death law
- Ethical and Economic issue in Health System and Transplantation
- Organ Donation
- Human Right (as a Vice President of International Federation of Human Right FIDH in Italy)
- Telemedicine (Scientific Director of INTERNATIONAL CENTER OF TELESCIENCE AND ADVANCE TELEMEDICINE)
- Writer
Giovanni Ambrosino, M.D.
13
SURGICAL EXPERIENCE
Over 8.000 major surgical procedure
300 Liver Transplant (donor and recipient)
700 Liver Resection
300 Bile Duct Cancer
500 Surgical Procedure in Emergency
200 Thoracic Surgery
300 Pancreatic Resection
100 Vascular Procedure
6700 Abdominal procedure for benign and neoplastic pathology (mostly colon rectal cancer, retroperitoneal cancer, peritoneal cancer – HIPEC and peritonectomy, Gastric cancer, GERD,etc.)
OTHERS
Hernia repair, Cholecystectomy, etc.
Prof. Giovanni Ambrosino M.D.
2022
outbern Qeuropean m;a k jforce
( trbome)
, •j11 j ' ; ••
o
Wniteb tates armp, Qfurope, anb ebentb mtp
is
croll of ppreciation -
is awa rb eb to
Ospedale S. Bortolo
Unita Operativa
di
CJfI'R'U.'R(jl.'A. (j'ENER'AL'E I
for
outstanding service to the Vicenza Military Community Caserma Ederle, Vicenza, Italy
17 December 2004
>:ZS4_1. J{ .. - __my
750 Welch Road Suite 319, Palo Alto, CA 94304 650-***-**** ********@********.*** STANFORD UNIVERSITY SCHOOL OF MEDICINE
Department of Surgery, Division of Abdominal Transplantation Carlos O. Esquivel, M.D., Ph.D., F.A.C.S.
The Arnold and Barbara Silverman Professor of Surgery Professor of Pediatrics, by courtesy
Chief, Division of Abdominal Transplantation
Associate Director, Institute of Immunity, Transplantation and Infection Surgical Director of the Liver Transplant Program at Stanford Hospital and Clinics and Lucile March Packard 20, 2020 Children’s at Stanford, Stanford School of Medicine US Department of Homeland Security
US Citizenship and Immigration Service
To Whom It May Concern:
My name is Carlos O. Esquivel, M.D., Ph.D., and I am the Chief of the Division of Abdominal Transplantation in the Stanford Department of Surgery, Co-Director and Associate Director of the Institute for Immunity, Transplantation and Infection, and a Professor of Surgery. I am writing this letter in support of Dr. Giovanni Ambrosino’s O-1 Extraordinary Ability visa application. Based on my knowledge of Dr. Ambrosino’s achievements to date, I am confident that he absolutely qualifies for this highly restrictive category. As a world-renowned adult and pediatric transplant surgeon, I launched my research career at the University of Lund in Sweden, and presented research throughout my career at the most renowned and highly-selective medical institutions in the world. I am very familiar with celebrated professionals in my field all over the globe, and Dr. Giovanni Ambrosino is one of these extraordinary professionals.
I have known Dr. Ambrosino for my entire career since I was a fellow at the University of Pittsburgh under transplant pioneer Prof. Thomas E. Starzl, M.D., Ph.D. I was appointed as Assistant Professor of Surgery in 1985 when Dr. Ambrosino joined the T. Starzl Transplantation Institute. Since then, we have remained international colleagues, and he is, in my expert opinion, one of the world’s foremost clinical, transplantation and oncology surgeons. Dr. Ambrosino is specifically known for his unparalleled expertise with bioartificial liver transplants, hepatocytes transplantation, domino liver transplants, and robotic stereotactic surgery. Dr. Ambrosino was a visiting scholar for several months in 1991 to the multi-organ transplant program at California Pacific Medical Center (Former Pacific Presbyterian Medical Center), whereby he shared his experience of developing innovative research programs in Italy. In his areas of expertise noted above, Dr. Ambrosino has achieved numerous internationally- celebrated and major original contributions of great significance to the medical field, particularly liver transplantation and treatment. Dr. Ambrosino pioneered the infusion of liver cells into patients diagnosed with a rare disorder affecting the liver to produce an important enzyme. This technique was developed to treat Crigler-Najjar syndrome in a painless way, avoiding liver 750 Welch Road Suite 319, Palo Alto, CA 94304 650-***-**** ********@********.*** transplant. He has made very important contributions in the multidisciplinary treatment of liver and pancreas cancer.
Dr. Ambrosino is a superb speaker. He has been invited to many educational programs sponsored by scientific societies as well as participating in educational programs on television and other digital platforms such as webinars, YouTube among others. Dr. Ambrosino is also a talented writer. He has authored numerous publications in peer review journals. But, his talents transcend medicine. He was the main author for a screenplay which won the FIRST WINNER PRIZE – Hollywood International Moving Picture Film Festival –Screenplay section in 2016. Dr. Ambrosino has clearly made a significant impact on the medical field and beyond through his outstanding work in liver transplantation, research, and treatment. I believe his work at major hospitals throughout Italy and abroad, as well as his membership in multiple prestigious medical organizations all prove his extraordinary ability as a surgeon and speak to the great benefit he would have if allowed to continue his work and research in the United States. Sincerely,
Carlos O. Esquivel, M.D., Ph.D.
The Arnold and Barbara Silverman Professor of Surgery and, by courtesy, of Pediatrics Chief, Division of Abdominal Transplantation, Stanford School of Medicine IGL Pharma, Inc.
1004 S. Velasco St. 6226 Lindyann LN
Houston, TX 77008 Houston, TX 77008
Tel. 979-***-**** Tel. 858-***-****
US Department of Homeland Security
US Citizenship and Immigration Service
To Whom It May Concern:
My name is C. Richard Piazza, PhD, and I am Executive Chairman of IGL Pharma Inc, a U.S. Biotech Company. I am writing this letter in support of Dr. Giovanni Ambrosino’s O-1 Extraordinary Ability visa application. Based on my knowledge of Dr. Ambrosino’s achievements to date, I am confident that he absolutely qualifies for this highly restrictive category.
In my position as President & CEO of ViatGen, Inc.(1993-2006), I had the pleasure of working with Dr. Giovanni Ambrosino, a truly extraordinary surgeon who was employed in a critical and essential capacity (Senior Clinical Advisor and Member, Medical Advisory Board) at VitaGen, Inc. from approximately 1997-2005. At ViatGen, Inc. we engaged Dr. Ambrosino because of his internationally-regarded skills as a highly- respected clinical, transplant and oncology surgeon and he was a great benefit to our overall operations. Specifically, Dr. Ambrosino made major contributions to our development of the world’s first bioartifical liver and his input in the design and clinical application was a critical part of our development program. Dr. Ambrosino’s knowledge and skill as a both a surgeon and clinical scientist provided a level of expertise that I felt was instrumental in our clinical advancement of the artificial liver. Further, Dr. Ambrosino had a “world view” in providing the background necessary to guide us in the development of our critical clinical trial. His insight and knowledge were invaluable to us. His expertise in assessing and treating acute liver failure provided us with the framework to determine the clinical utility and application of the artificial liver. He is a truly groundbreaking pioneer in his field and brought VitaGen, Inc. significant international visibility and renown through his incredible medical achievements and contributions. Clearly, Dr. Ambrosino’s work has been incredibly crucial to ViatGen’s mission of providing the best health outcomes for patients, as well as enhancing the company’s reputation as a pioneer of ground-breaking technologies. Additionally, it is important to note that Dr. Ambrosino made numerous original medical and scientific contributions of major significance during his time as a clinical advisor to Vitgen, Notably, Dr. Ambrosino’s helped create true firsts in determining the use of the artificial liver in keeping patients alive and even recovering their own liver function thus avoiding a transplant. It was Dr. Ambrosino’s insight that helped to expand our applications from simply a transplant bridge (i.e. keeping a patient in liver failure alive until a transplant was available) to extending its use allowing patients the opportunity to regain native liver function. Perhaps most significant was his insight in how to use the artificial liver in a fashion that allowed oncology surgeons to be more surgically aggressive in liver resection (i.e. tumor removal) that would help achieve better outcomes. Dr. Ambrosino’s tenure with us would qualify as both “original” and of
“major significance” to the field of liver treatment. This description should not only describe the contribution itself, but the impact the contribution has had in the field of medicine. There can be no doubt that Dr. Ambrosino’s contributions have had a significant impact on the field of medicine, not just in the U.S. but internationally. The contributions Dr. Ambrosino has made to the field of medicine are remarkable and absolutely qualify him for a visa in the United States. The methods and surgical techniques that he developed have ground-breaking implications in the medical community and I believe he is an invaluable asset who will continue to carry modern medicine forward in the coming years. Thus, I urge the expedient approval of his visa petition. If I can be of any further assistance, or provide you with any further information, please do not hesitate to contact me.
Sincerely,
C. Richard Piazza, PhD
President & Chief Executive Officer
IGL Pharma Inc.
6226 Lindyann LN
Houston, TX 77008
Tel. 858-***-****
*******@***.***
********.****@*****.***
980 Johnson Ferry Road NE., Suite 430 Atlanta, GA 30342, 2665 North Decatur Road, Suite 730, Decatur, GA 30033-6148 Phone 404-***-**** Fax 404-***-**** www.dekalbsurgical.com John S. Kennedy, M.D., F.A.C.S., David R. Fern, M.D., F.A.C.S., Michael S. Champney, M.D., F.A.C.S., Andrei Stieber, M.D., F.A.C.S. March 17, 2020
US Department of Homeland Security
US Citizenship and Immigration Service
To Whom It May Concern:
My name is Andrei C Stieber, M.D, F.A.C.S., and I am a recently retired transplant and HPB surgeon. I am writing this letter in support of Dr. Giovanni Ambrosino’s O-1 Extraordinary Ability visa application. Based on my knowledge of Dr. Ambrosino’s achievements to date, I am confident that he absolutely qualifies for this highly restrictive category. As a respected transplant surgeon in the field of organ transplantation, I have worked both at the University of Pittsburgh on the team of dr. Thomas E. Starzl, the father of liver transplantation, from May 1985 to August 1992 and at Emory University in Atlanta as the co-director of the Liver Transplant Program (1992-2008) and am familiar with numerous noted professionals in my field. Dr. Giovanni Ambrosino is one of these extraordinary professionals. I have known him since 1985 and, starting in late that year, he became my go to surgeon to both assist me with my own cases and for me to assist in cases he did during his training. He struck me very early as an extremely talented surgeon, whom I trusted in any circumstance. In addition, he did crucial research in hepatocyte (the intrinsic liver cell) regeneration and pancreatic cell transplantation. Subsequently, he continued to do exceptional, cutting edge research in pancreatic cell transplant and bio-artificial liver. His bio-artificial liver was awarded a patent and was successfully used as a life-saving apparatus. In the clinical field, he became one of the best and most skilled transplant and HPB surgeons, widely respected and a member of the most rarefied group at the top of this field. In his areas of expertise noted above, Dr. Ambrosino has achieved numerous internationally celebrated and major original contributions of great significance to the medical field, particularly liver transplantation and treatment. Specifically, he has performed domino transplants (these can be, for instance, cases in in which a recipient’s own liver is not necessarily damaged, but causing damage to its owner’s body due to metabolic problems and is replaced via transplant, but then the removed organ can be donated to another patient on the list who will not be affected metabolically). He also pioneered robotic surgical techniques that have advanced this newer field of surgery.
980 Johnson Ferry Road NE., Suite 430 Atlanta, GA 30342, 2665 North Decatur Road, Suite 730, Decatur, GA 30033-6148 Phone 404-***-**** Fax 404-***-**** www.dekalbsurgical.com Dr. Ambrosino has clearly made a significant impact on the medical field through his outstanding work in liver transplantation, research, and treatment. I believe his work at major hospitals throughout Italy and abroad, as well as his membership in multiple prestigious medical organizations all prove his extraordinary ability as a surgeon and speak to the great benefit he would provide if allowed to continue his work and research in the United States. Sincerely,
Andrei C. Stieber, M.D., F.A.C.S.
Phone: 404-***-****
Mobile: 404-***-****
Fax: 404-***-****
********@**********.***
April 24, 2020
US Department of Homeland Security
US Citizenship and Immigration Service
To Whom It May Concern:
My name is Davide D’Amico and I am Full Professor of Surgery University of Padova
(Italy), Chairman of the Department of General Surgery and Liver Transplant Program, University Hospital of Padova. Past President of Italian Surgery Society and European Transplantation Society, President of HPB Italian Chapter. I am writing this letter in support of Dr. Giovanni Ambrosino’s O-1 visa application. Based on my knowledge of Dr. Ambrosino’s achievements to date, I am confident that he absolutely qualifies for this highly restrictive category. This letter is to confirm that Dr. Giovanni Ambrosino is an official member of the:
- Academy of Surgical Science. The special Academy promotes the advancement of professional and academic standards, education and research in the arts and sciences of experimental surgery. The Academy interfaces with medical and scientific organizations, and governmental agencies in establishing and reviewing ethics, theories, practices and research pertaining to surgery and promotion of the results for clinical application.
- Massachusetts General Hospital – Member of Italian alumni Association; an exclusive association created by the Harvard Medical School in collaboration with Mass General Hospital. Ambrosino won a prestigious International award.
- ASAIO (formerly known as the American Society for Artificial Internal Organs) is a world class society that has been in existence for over 64 years.
- SCIENTIFIC DIRECTOR OF ICTAT - International Center of Telemedicine and Tele Science – Miami – President Prof Camillo Ricordi, Director of DRI, University of Miami. A Society of Experts in those field in the world.
- SIC – Italian Surgical Society
- Italian President of SICP – for the Emergency Surgery
- Italian Vice President. Head of scientific programs of FIDH (International Federation for Human Rights) is an international human rights NGO federating 192 organisations from 117 countries. Since 1922, FIDH has been defending all civil, political, economic, social and cultural rights as set out in the Universal Declaration of Human Rights.
- WHO’S WHO IN HEALTCARE AND MEDICINE – a book that recognizes those whose achievements place them at the forefront of an evolving healthcare system. Dr. Ambrosino is listed as researcher - first in the world to perform a cellular transplantation in a rare genetic disease and Firs to use a Bioartificial Liver Support in a patient with acute liver failure.
- Editor: International Journal of Transplantation Research Dr. Ambrosino has been a member of all these organizations and was granted membership into this exclusive organization based on his outstanding achievements as a surgeon, particularly his specialization in liver transplantation, research, and treatment. Dr. Ambrosino thanks to the numerous researches of which he has been international head some of which have resulted in first procedures in the world that bear his name, in the field of transplants and artificial organs, contributed significantly to the therapies of some rare diseases and to the study of bioartificial organs
Needless to say, membership in all the above Organizations are incredibly selective and only the most accomplished surgeons and medical professionals are granted membership. We are proud to have Dr. Ambrosino as one of our illustrious members and are excited to see his contributions to the medical field in the coming years. The contributions Dr. Ambrosino has made to the field of medicine and liver transplantation and treatment are second to none and make me confident that he would be a great benefit to U.S. medical institutions. I have no doubt that the surgical methods and technologies that he developed will surely have ground-breaking implications in the field and that his skills would be an invaluable asset to the U.S. medical field. Thus, I urge the expedient approval of his visa petition.
Sincerely,
Davide D’Amico
Contact this candidate